Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting glucocorticoid-induced TNFR-associated protein (GITR). Ragifilimab can be used in the study of advanced or metastatic solid tumors.
CAS Number:
[2207590-51-8]
Target:
CM-701 , INCAGN-1876 , INCAGN-01876
* VAT and and shipping costs not included. Errors and price changes excepted